Has Paul Jellinger, MD received payments from drug or device companies?

Yes. Drug and device makers reported $159,188 in general payments to Paul Jellinger, MD across 527 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Jellinger, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Jellinger, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Jellinger, MD

Endocrinology, Diabetes & Metabolism · Hollywood, FLNPI 1811900665

Payments from drug & device makers

$159,188in general payments, 2019–2025

Across 527 payments — averaging $302.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$42K
Amarin Pharma, Inc.$29K
Esperion Therapeutics, Inc.$19K
Sanofi-aventis U.S. LLC$16K
Corcept Therapeutics$12K
Regeneron Healthcare Solutions, Inc.$11K
plus $31K from 41 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen(2 entities)	85	$41,505
Amarin Pharma, Inc.	39	$28,742
Esperion Therapeutics, Inc.	22	$19,020
Sanofi-aventis U.S. LLC	28	$15,963
Corcept Therapeutics	21	$11,819
Regeneron Healthcare Solutions, Inc.	19	$11,084
AstraZeneca	31	$10,977
Regeneron	4	$9,744
Siemens Medical Solutions USA, Inc.	1	$3,617
Novo Nordisk	133	$2,393
Abbott	7	$455
Tandem Diabetes Care, Inc.	3	$445
Novartis	19	$381
Merck	4	$335
Dexcom, Inc.	13	$293
Boehringer Ingelheim	6	$251
Insulet Corporation	8	$188
AbbVie	9	$162
Madrigal Pharmaceuticals	3	$147
Verity Pharmaceuticals Inc.	6	$138
Ascendis Pharma Endocrinology Inc	3	$131
Xeris Pharmaceuticals, Inc.	6	$122
Mannkind Corporation	4	$101
Bayer	3	$96
Senseonics, Incorporated	4	$94
Shire North American Group Inc	2	$87
Medtronic	4	$85
Pfizer	4	$82
Lexicon Pharmaceuticals, Inc.	1	$79
Lilly USA, LLC	4	$69
Johnson & Johnson	4	$60
Alvogen Inc	3	$54
BETA Bionics, Inc.	3	$53
Cequr Corporation	3	$51
Kyowa Kirin, Inc.	2	$50
Medicure Pharma Inc.	1	$49
IBSA Pharma Inc.	2	$44
Sequel Med Tech, LLC	2	$37
Tolmar, Inc.	2	$30
Lifescan, Inc.	1	$29
GRT US Holding, Inc.	2	$26
Clarus Therapeutics Inc.	1	$20
Amryt Pharma Holdings Ltd	1	$20
Kowa Pharmaceuticals America, Inc.	1	$18
Vivus LLC	1	$16
Recordati_rare_diseases_inc.	1	$16
Amneal Pharmaceuticals LLC	1	$15

How this compares

$159,188 in reported general payments places this provider in the 90th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

See all endocrinology, diabetes & metabolism providers in Florida →

Medicare billing

Part B allowed, 2024

$186,083

Medicare patients

275

Services billed

8,487

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Hollywood

Lorena Lewy-AlterbaumHollywood$3.1M
Sam LermanHollywood$1.8M
Richard PratleyOrlando$9.2M
Jose MandryOcoee$9.1M
Steven SmithOrlando$7.9M
Barry HorowitzWest Palm Beach$7.1M
Tina ThethiOrlando$3.8M
David SuttonJacksonville$3.1M
Mae Sheikh AliJacksonville$2.9M
James MageeJacksonville$2.7M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →